Robert D. Allen III, Chief Scientific Officer at Invivyd, Inc. (IVVD), sold 37,722 shares at $0.72 ($29K) on 2026-08-17, disclosed to the SEC on 2026-08-18.
Scheduled sale ($29k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.72 | 20,679 | $15K | 51.0% |
| 2 | $0.84 | 17,043 | $14K | 49.0% |
| Total | $0.78 avg | 37,722 | $29K | 100% |
| Filing → |